These findings suggest that CDK1, STAT1, COL1A2, and COL1A1 may be involved in the AKI process associated with gastrointestinal cancers through mechanisms such as cell cycle regulation and inflammation, highlighting their potential as early predictive and diagnostic biomarkers for AKI. The gene discussed is STAT1; the disease is acute kidney injury.